You have skipped the navigation, tab for page content

The National Rugby League (NRL) Anti-Doping Tribunal has imposed a 20-month suspension on former NRL Player James Segeyaro.

The Anti-Doping Tribunal, chaired by the Honourable Ian Callinan AC QC with panellists Dr Sharron Flahive and Mr Sean Garlick, found that Mr Segeyaro breached the NRL’s Anti-Doping Policy in September 2019 when he tested positive to the presence of Di-Hydroxy LGD-4033 (Ligandrol).

In considering the circumstances of the breach, the Tribunal found that whilst Mr Segeyaro bore a significant degree of responsibility for the positive result, he had not intentionally taken the Ligandrol, which was likely to have entered his system via the use of a food blender maintained by a member of his household that contained residues of the substance.  Having been satisfied that the doping was not intentional, the Tribunal determined that Mr Segeyaro was entitled to a reduced sanction under the WADA Code.

Mr Segeyaro’s suspension is taken to have commenced on the date of his provisional suspension on 3 October 2019 and will expire on 2 June 2021.

Acknowledgement of Country

National Rugby League respects and honours the Traditional Custodians of the land and pay our respects to their Elders past, present and future. We acknowledge the stories, traditions and living cultures of Aboriginal and Torres Strait Islander peoples on the lands we meet, gather and play on.

Premier Partner

Media Partners

Major Partners

View All Partners